JNJ
Johnson & Johnson
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Johnson & Johnson (JNJ), founded in 1886, is a premier American multinational corporation at the forefront of the global healthcare sector, acclaimed for its diversified product offerings in pharmaceuticals, medical devices, and consumer health products. With an unwavering commitment to innovation a...
$273.20
-0.73% ($2.00)
Volume
8.97M
52W High
$282.02
52W Low
$185.12
Market Cap
$603.74B
Next Earnings Report
Last Reported
Oct 13, 2026 Beat
Actual: $2.59
vs. Consensus: $2.53
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q3 2026
Oct 13, 2026
1-Day:
+2.13%
Q2 2026
Jul 15, 2026
1-Day:
+1.19%
5-Day:
+0.73%
Q1 2026
Apr 14, 2026
1-Day:
-0.60%
Q4 2025
Jan 21, 2026
1-Day:
+0.22%
5-Day:
+1.60%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'26 | $25.40B | +5.9% | 73.0% | 25.1% | $210.0M |
| Q2'26 | $25.31B | +6.6% | 68.2% | 28.3% | $5.53B |
| Q1'26 | $24.06B | +9.9% | 66.3% | 26.6% | $5.24B |
| Q4'25 | $24.56B | +9.1% | 67.6% | 22.8% | $5.12B |
| Q3'25 | $23.99B | +6.8% | 69.6% | 29.6% | $5.15B |
| Q2'25 | $23.74B | +5.8% | 67.9% | 28.7% | $5.54B |
| Q1'25 | $21.89B | +2.4% | 66.4% | 28.8% | $11.00B |
| Q4'24 | $22.52B | +5.3% | 68.4% | 17.1% | $3.43B |
Company Information
Symbol
JNJ
Company
Johnson & Johnson
Market Cap
$603.74B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare JNJ with competitors
Side-by-side earnings comparison